DCK antibody [GT7710]
GTX632062
ApplicationsWestern Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman, Mouse, Rat
TargetDCK
Overview
- SupplierGeneTex
- Product NameDCK antibody [GT7710]
- Delivery Days Customer9
- Application Supplier NoteWB: 1:1000-1:10000. IHC-P: 1:100-1:1000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsWestern Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDGT7710
- Concentration1.33 mg/ml
- ConjugateUnconjugated
- Gene ID1633
- Target nameDCK
- Target descriptiondeoxycytidine kinase
- Target synonymsdeoxyadenosine kinase; deoxycytidine kinase; deoxyguanosine kinase; deoxynucleoside kinase
- HostMouse
- IsotypeIgG1
- Protein IDP27707
- Protein NameDeoxycytidine kinase
- Scientific DescriptionDeoxycytidine kinase (DCK) is required for the phosphorylation of several deoxyribonucleosides and their nucleoside analogs. Deficiency of DCK is associated with resistance to antiviral and anticancer chemotherapeutic agents. Conversely, increased deoxycytidine kinase activity is associated with increased activation of these compounds to cytotoxic nucleoside triphosphate derivatives. DCK is clinically important because of its relationship to drug resistance and sensitivity. [provided by RefSeq]
- ReactivityHuman, Mouse, Rat
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- Decreased drug resistance of bladder cancer using phytochemicals treatment. Cho CJ et al., 2021 Feb, Kaohsiung J Med SciRead more